Atlas Trials

A Clinical Study to Assess the Effect of Clopidogrel on the Pharmacokinetics of Selexipag and Its Active Metabolite in Healthy Male Subjects

Clinical trial NCT03496506 · COMPLETED

Trial details

NCT number
NCT03496506
Sponsor
Actelion
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2018-03-05
Primary completion
2018-05-10
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.